Martin MacKay's Net Worth
$23.2 Million
Who is Martin MacKay?
Martin MacKay has an estimated net worth of $23.2 Million. This is based on reported shares across multiple companies, which include PFIZER INC, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., Rallybio Corp, 5:01 Acquisition Corp., ALEXION PHARMACEUTICALS INC, and ENCYSIVE PHARMACEUTICALS INC.
SEC CIK
Martin MacKay's CIK is 0001414815
Past Insider Trading and Trends
2009 was Martin MacKay's most active year for acquiring shares with 25 total transactions. Martin MacKay's most active month to acquire stocks was the month of January. 2016 was Martin MacKay's most active year for disposing of shares, totalling 10 transactions. Martin MacKay's most active month to dispose stocks was the month of January. 2013 saw Martin MacKay paying a total of $10,486,000.00 for 125,000 shares, this is the most they've acquired in one year. In 2015 Martin MacKay cashed out on 95,323 shares for a total of $15,610,885.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PFIZER INC (PFE) Snapshot price: $27.565
Senior Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +22.29% | 68.36K |
$17.69 | -$19,936.63 | 375.04K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +78.80% | 131.15K |
$12.70 | -$74,129.90 | 297.58K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
| +36.90% | 43K |
$22.55 | -$36,170.20 | 159.53K |
Feb 28
| |||
Form 4
| +5.73% | 6.25K |
—
|
—
| 115.25K |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Snapshot price: $219.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.03% | 931 |
$228.41 | $212,649.71 | 12.53K |
May 13
| |||
Form 4
| +0.83% | 95 |
—
|
—
| 11.6K |
Jul 3
| |||
Form 4
| +3.03% | 338 |
—
|
—
| 11.51K |
May 31
| |||
Form 4
| +6.32% | 664 |
—
|
—
| 11.17K |
May 15
| |||
Form 4
| +8.70% | 841 |
—
|
—
| 10.5K |
May 11
| |||
Form 4
| +0.66% | 63 |
—
|
—
| 9.66K |
Jan 3
| |||
Form 4
| +6.36% | 574 |
—
|
—
| 9.6K |
May 7
| |||
Form 4
| +15.31% | 1.2K |
—
|
—
| 9.03K |
May 11
| |||
Form 4
| +46.41% | 2.48K |
—
|
—
| 7.83K |
May 22
| |||
Form 4
| +92.16% | 2.56K |
—
|
—
| 5.35K |
May 14
| |||
Form 4
|
∞
| 2.78K |
—
|
—
| 2.78K |
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rallybio Corp (RLYB) Snapshot price: $1.65
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
∞
| 719.13K |
$10.35 |
—
| 719.13K |
Jul 28 - Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
5:01 Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALEXION PHARMACEUTICALS INC No price found
EVP & Global Head R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.54% | 10.95K |
$131.63 | -$244,169.50 | 50.69K |
Feb 27 - Mar 1
| |||
Form 4
| -0.54% | -217.00 |
$126.84 | -$27,524.28 | 39.74K |
Feb 9
| |||
Form 4
| -6.39% | -2.73K |
$125.70 | -$342,903.74 | 39.96K |
Feb 6
| |||
Form 4
| -8.76% | -4.10K |
$139.20 | -$570,283.75 | 42.69K |
May 16
| |||
Form 4
| +14.71% | 6K |
$138.91 | -$138,910.00 | 46.78K |
Feb 26 - Feb 29
| |||
Form 4
| +23.99% | 7.89K |
$142.69 | -$540,749.73 | 40.78K |
Feb 4 - Feb 8
| |||
Form 4
|
—
|
0
|
$163.41 | -$2,880,930.72 | 32.89K |
Aug 3
| |||
Form 4
| -10.98% | -4.06K |
$160.33 | -$650,298.48 | 32.89K |
May 14
| |||
Form 4
| +14.68% | 4.73K |
$180.34 | -$66,725.80 | 36.95K |
Feb 27 - Mar 2
| |||
Form 4
| -10.79% | -3.90K |
$173.97 | -$677,955.87 | 32.22K |
Feb 10
| |||
Form 4
| +47.86% | 11.69K |
—
|
—
| 36.12K |
Feb 5
| |||
Form 4
|
—
|
0
|
$148.19 | -$812,437.50 | 24.43K |
Nov 3
| |||
Form 4
|
—
|
0
|
$135.64 | -$1,539,065.39 | 24.43K |
Jun 12
| |||
Form 4
| -12.76% | -3.57K |
$160.85 | -$574,877.90 | 24.43K |
May 14
| |||
Form 4
| +12.00% | 3K |
—
|
—
| 28K |
Feb 28
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||